Why Homogenate Dilution Requires a Correction
Tissue fraction unbound, \(f_{u,\mathrm{tissue}}\), describes the unbound concentration relative to the total concentration in intact tissue under specified conditions. Measuring it directly can be difficult. A common approach is to homogenize tissue, measure the fraction unbound in the homogenate, and correct for the dilution of tissue binding components caused by adding buffer.
The homogenate measurement is not itself the intact-tissue value: added buffer lowers the concentration of binding components relative to the drug. Under a simple equilibrium model, this makes the homogenate fraction unbound higher than the corresponding intact-tissue fraction. The correction estimates the intact-tissue value by accounting for how much the tissue was diluted.
When tissue amount is recorded by mass, the tissue-equivalent volume requires a density assumption or a protocol-specific conversion. For example, if 1 g of tissue is treated as 1 mL and homogenized with 3 mL of buffer to a final volume of 4 mL, then \(D=4\). The phrase “one part tissue to three parts buffer” therefore corresponds to a fourfold final-volume dilution under this convention, not a threefold dilution. Use the preparation protocol’s actual definition and volumes rather than inferring \(D\) from shorthand.
Deriving the Dilution Correction
For a binding system at equilibrium, the bound-to-unbound ratio is \(1/f_u-1\), because the unbound fraction is the unbound concentration divided by total concentration. In the correction model, homogenization dilutes tissue binding components by a factor of \(D\), while the binding affinity and equilibrium relationship are unchanged. Therefore, the bound-to-unbound ratio in the homogenate is the intact-tissue ratio divided by \(D\).
Rearrange to solve for the intact-tissue value. Multiply both sides by \(D\), add 1 to both sides, and take the reciprocal:
The model assumes reversible binding at equilibrium, with binding capacity diluted in proportion to the tissue-equivalent volume. It also assumes that homogenization and buffer addition do not materially change binding affinity, pH, relevant tissue composition, or the measured free concentration. The calculation presumes that the assay returns a valid \(f_{u,\mathrm{hom}}\) and that the specified dilution factor represents the preparation. If binding is strongly concentration-dependent, or if the assay has substantial nonspecific loss or incomplete recovery, a single corrected value may not represent intact tissue binding.
Worked Example: Correcting a Homogenate Measurement
In a hypothetical experiment, tissue is homogenized to a final dilution factor \(D=4\). The measured homogenate fraction unbound is \(f_{u,\mathrm{hom}}=0.080\). Estimate the intact-tissue fraction unbound using the correction model.
Substitute the measured value and dilution factor into the formula:
The estimated intact-tissue fraction unbound is \(0.02128\), or about 2.13%. This is lower than the homogenate value of 8.00%, as expected when the homogenate has fewer binding components per unit volume than intact tissue. The estimate is conditional on the model assumptions and the stated \(D=4\).
Worked Calculations and Checks
A reliable calculation begins with the preparation details, not just the reported assay result. Confirm the final homogenate volume, tissue amount, and conversion used to express tissue amount as an equivalent volume. Then calculate \(D\), verify that the measured fraction and \(D\) are valid inputs, and apply the correction.
Worked Example: Calculating the Dilution Factor From Preparation Volumes
In a hypothetical protocol, 0.50 mL of tissue-equivalent volume is combined with buffer to make 2.00 mL of final homogenate. The measured \(f_{u,\mathrm{hom}}\) is 0.20. Calculate \(D\) and estimate \(f_{u,\mathrm{tissue}}\).
First, calculate the dilution factor using final volume divided by tissue-equivalent volume:
The units cancel, so \(D\) is dimensionless. Now apply the correction:
The estimated intact-tissue fraction unbound is \(0.05882\), or 5.88%. A common preparation error would be to use the buffer volume, 1.50 mL, as the final volume and calculate \(D=3\). That would not follow the stated definition: the final volume is 2.00 mL, so the correct dilution factor is 4.00.
Several limiting cases provide quick checks. If \(D=1\), there is no dilution and the formula returns \(f_{u,\mathrm{tissue}}=f_{u,\mathrm{hom}}\). If \(f_{u,\mathrm{hom}}=1\), the model gives \(f_{u,\mathrm{tissue}}=1\), because there is no binding in the measured homogenate under the model. For \(D>1\) and \(0<f_{u,\mathrm{hom}}<1\), the correction gives \(0<f_{u,\mathrm{tissue}}<f_{u,\mathrm{hom}}\). A result outside the interval from 0 to 1 indicates an input or calculation problem, not a valid fraction unbound.
Worked Example: Checking the Effect of Dilution
Two hypothetical aliquots from the same tissue preparation are measured at different dilution factors. At \(D=2\), the homogenate value is 0.0526; at \(D=5\), it is 0.0260. Correct each value and assess whether the estimates are consistent.
For the first aliquot:
For the second aliquot:
The corrected estimates, about 0.0270 and 0.00531, differ substantially. Under ideal assumptions, different dilutions of the same tissue should imply approximately the same intact-tissue value. The discrepancy is a diagnostic signal: investigate the measured values, dilution calculations, assay precision, concentration dependence, and whether the model assumptions hold. It is not appropriate to average the estimates automatically and treat the result as validated.
Assumptions, Diagnostics, and Alternatives
The correction is a model-based conversion, not a universal property of homogenate assays. In particular, the derivation treats binding as an equilibrium relationship in which reducing tissue concentration by \(D\) reduces the bound-to-unbound ratio by the same factor. It can be inadequate if homogenization changes the binding environment, if binding is saturable over the relevant concentration range, or if the assay does not measure equilibrium free drug accurately. The measured \(f_{u,\mathrm{hom}}\), drug concentration, and dilution factor must refer to conditions that are interpretable together.
Useful diagnostics include checking that the corrected result is between 0 and 1, that it is lower than the homogenate result when \(D>1\), and that the calculation uses the final homogenate volume. If measurements at multiple dilutions are available, apply the correction separately to each. Large disagreement among corrected values suggests that at least one input or assumption needs review. Very small \(f_{u,\mathrm{hom}}\) values can also make the result sensitive to measurement error: the formula contains \(1/f_{u,\mathrm{hom}}\), so small absolute errors in a low measured fraction may substantially affect the corrected estimate.
| Approach | What it provides | Main limitation |
|---|---|---|
| Homogenate measurement with dilution correction | An estimate of intact-tissue fraction unbound from a homogenate assay and \(D\) | Depends on the equilibrium and dilution assumptions, as well as assay validity |
| Measurement in intact tissue | A value measured without applying the homogenate dilution correction | May be technically difficult and still requires control of measurement conditions |
| Uncorrected homogenate fraction | The measured fraction unbound in the diluted homogenate | Does not account for the dilution of tissue binding components |
Direct measurement in intact tissue can avoid this particular dilution conversion, but it is not automatically free of experimental limitations. Conversely, the corrected homogenate approach can be practical when intact-tissue measurement is difficult, provided its assumptions are defensible. The correction should not be confused with a prediction of tissue-to-plasma partitioning, nor does it by itself establish how tissue fraction unbound compares across organs.
Common Mistakes
- Using buffer volume as the final volume. If \(D\) is defined as final homogenate volume divided by tissue-equivalent volume, use the total final volume, including tissue.
- Multiplying the homogenate fraction by \(D\). The correction is not \(D f_{u,\mathrm{hom}}\). It acts on the bound-to-unbound ratio, giving \(f_{u,\mathrm{tissue}}=1/[1+D(1/f_{u,\mathrm{hom}}-1)]\).
- Assuming the corrected number is an exact intact-tissue measurement. It is an estimate conditional on the dilution model, the assay, and the preparation details.
- Ignoring inconsistent corrected estimates. Different dilution conditions should be checked for agreement under the model; substantial disagreement calls for investigation rather than automatic pooling.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- A preparation uses 0.25 mL tissue-equivalent volume and has a final homogenate volume of 1.00 mL. What is \(D\)?
- If \(f_{u,\mathrm{hom}}=0.10\) and \(D=3\), calculate \(f_{u,\mathrm{tissue}}\).
- For \(D>1\) and \(0<f_{u,\mathrm{hom}}<1\), should the corrected value be higher or lower than the homogenate value? Explain using the formula.
- Name two assumptions that could fail and make the correction unreliable.
- Two dilution conditions give markedly different corrected estimates. What is an appropriate interpretation?
Solutions. (1) \(D=1.00/0.25=4.00\), dimensionless. (2) \(f_{u,\mathrm{tissue}}=1/[1+3(1/0.10-1)]=1/[1+3(9)]=1/28=0.03571\), or 3.571%. (3) The corrected value is lower: for \(D>1\), the denominator \(1+D(1/f_{u,\mathrm{hom}}-1)\) exceeds \(1/f_{u,\mathrm{hom}}\), so its reciprocal is less than \(f_{u,\mathrm{hom}}\). (4) Examples include a change in binding affinity or pH during homogenization, failure to reach equilibrium, concentration-dependent binding, or substantial nonspecific assay loss. (5) The disagreement is a diagnostic signal that inputs, assay behavior, or model assumptions need review; the estimates should not be treated as interchangeable without investigation.